US Stock MarketDetailed Quotes

GOVX GeoVax Labs

Watchlist
  • 2.4300
  • -0.1800-6.90%
Close Nov 15 16:00 ET
  • 2.3900
  • -0.0400-1.65%
Post 19:59 ET
22.93MMarket Cap-289P/E (TTM)

GeoVax Labs Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
67.85%-1.94M
-51.05%-5.68M
-32.28%-25.17M
-45.49%-10.28M
-34.13%-5.1M
-57.48%-6.04M
13.16%-3.76M
-69.97%-19.03M
-5.70%-7.06M
-132.55%-3.8M
Net income from continuing operations
14.57%-5.06M
-44.88%-5.85M
-85.20%-25.97M
-41.02%-7.59M
-111.91%-8.41M
-164.43%-5.93M
-66.34%-4.04M
24.50%-14.02M
60.83%-5.38M
-103.44%-3.97M
Depreciation and amortization
37.10%23.74K
13.03%19.58K
31.78%74.17K
57.86%22.21K
-2.01%17.32K
41.15%17.32K
41.16%17.32K
46.11%56.28K
20.11%14.07K
97.82%17.68K
Change In working capital
856.29%3M
-193.36%-10.91K
94.03%-356K
-52.61%-2.97M
3,534.27%3M
78.12%-396.36K
100.55%11.69K
-186.14%-5.97M
-128.09%-1.95M
-810.39%-87.29K
-Change in receivables
----
----
--0
--0
--0
----
----
-63.33%49.01K
--0
--0
-Change in prepaid assets
96.52%112.39K
10.44%-677.03K
90.18%-114.49K
590.40%592.6K
97.34%-8.3K
107.14%57.19K
-446.35%-755.97K
-7,064.75%-1.17M
169.64%85.83K
-975.08%-312.05K
-Change in payables and accrued expense
752.91%2.96M
-3.42%-215.97K
54.31%-1.23M
-74.47%-3.56M
110.77%3M
-240.41%-453.54K
89.20%-208.84K
-139.46%-2.69M
-128.75%-2.04M
6,182.22%1.42M
-Change in other current assets
--224.68K
-9.67%882.1K
145.60%986.5K
--0
100.84%10K
--0
--976.5K
---2.16M
--10K
---1.2M
Cash from discontinued investing activities
Operating cash flow
67.85%-1.94M
-51.05%-5.68M
-32.28%-25.17M
-45.49%-10.28M
-34.13%-5.1M
-57.48%-6.04M
13.16%-3.76M
-69.97%-19.03M
-5.70%-7.06M
-132.55%-3.8M
Investing cash flow
Cash flow from continuing investing activities
63.54%-48.95K
-18.95K
88.06%-6.19K
-181.36%-134.26K
0
-86.67%-51.88K
Net PPE purchase and sale
----
----
63.54%-48.95K
---18.95K
88.06%-6.19K
----
----
-181.36%-134.26K
--0
-86.67%-51.88K
Cash from discontinued investing activities
Investing cash flow
----
----
63.54%-48.95K
---18.95K
88.06%-6.19K
----
----
-181.36%-134.26K
--0
-86.67%-51.88K
Financing cash flow
Cash flow from continuing financing activities
-88.51%4.06M
4.06M
0
176.54%35.35M
0
3,215.45%7.63M
Net common stock issuance
----
----
--0
--0
--0
----
----
194.69%27.73M
--0
--0
Proceeds from stock option exercised by employees
----
----
-46.73%4.06M
--4.06M
--0
----
----
124.02%7.63M
--0
3,215.45%7.63M
Cash from discontinued financing activities
Financing cash flow
----
----
-88.51%4.06M
--4.06M
--0
----
----
176.54%35.35M
--0
3,215.45%7.63M
Net cash flow
Beginning cash position
-96.78%768.86K
-76.63%6.45M
141.71%27.61M
-63.41%12.69M
-42.44%17.79M
46.70%23.85M
141.71%27.61M
15.58%11.42M
91.51%34.68M
58.16%30.9M
Current changes in cash
113.08%792.85K
-51.05%-5.68M
-230.71%-21.16M
11.75%-6.23M
-235.17%-5.1M
-141.39%-6.06M
-177.84%-3.76M
951.17%16.19M
-5.70%-7.06M
363.68%3.77M
End cash Position
-91.22%1.56M
-96.78%768.86K
-76.63%6.45M
-76.63%6.45M
-63.41%12.69M
-42.44%17.79M
46.70%23.85M
141.71%27.61M
141.71%27.61M
91.51%34.68M
Free cash flow
67.97%-1.94M
-51.05%-5.68M
-31.61%-25.22M
-45.76%-10.3M
-32.48%-5.1M
-57.27%-6.06M
14.39%-3.76M
-70.44%-19.16M
-5.70%-7.06M
-131.78%-3.85M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 67.85%-1.94M-51.05%-5.68M-32.28%-25.17M-45.49%-10.28M-34.13%-5.1M-57.48%-6.04M13.16%-3.76M-69.97%-19.03M-5.70%-7.06M-132.55%-3.8M
Net income from continuing operations 14.57%-5.06M-44.88%-5.85M-85.20%-25.97M-41.02%-7.59M-111.91%-8.41M-164.43%-5.93M-66.34%-4.04M24.50%-14.02M60.83%-5.38M-103.44%-3.97M
Depreciation and amortization 37.10%23.74K13.03%19.58K31.78%74.17K57.86%22.21K-2.01%17.32K41.15%17.32K41.16%17.32K46.11%56.28K20.11%14.07K97.82%17.68K
Change In working capital 856.29%3M-193.36%-10.91K94.03%-356K-52.61%-2.97M3,534.27%3M78.12%-396.36K100.55%11.69K-186.14%-5.97M-128.09%-1.95M-810.39%-87.29K
-Change in receivables ----------0--0--0---------63.33%49.01K--0--0
-Change in prepaid assets 96.52%112.39K10.44%-677.03K90.18%-114.49K590.40%592.6K97.34%-8.3K107.14%57.19K-446.35%-755.97K-7,064.75%-1.17M169.64%85.83K-975.08%-312.05K
-Change in payables and accrued expense 752.91%2.96M-3.42%-215.97K54.31%-1.23M-74.47%-3.56M110.77%3M-240.41%-453.54K89.20%-208.84K-139.46%-2.69M-128.75%-2.04M6,182.22%1.42M
-Change in other current assets --224.68K-9.67%882.1K145.60%986.5K--0100.84%10K--0--976.5K---2.16M--10K---1.2M
Cash from discontinued investing activities
Operating cash flow 67.85%-1.94M-51.05%-5.68M-32.28%-25.17M-45.49%-10.28M-34.13%-5.1M-57.48%-6.04M13.16%-3.76M-69.97%-19.03M-5.70%-7.06M-132.55%-3.8M
Investing cash flow
Cash flow from continuing investing activities 63.54%-48.95K-18.95K88.06%-6.19K-181.36%-134.26K0-86.67%-51.88K
Net PPE purchase and sale --------63.54%-48.95K---18.95K88.06%-6.19K---------181.36%-134.26K--0-86.67%-51.88K
Cash from discontinued investing activities
Investing cash flow --------63.54%-48.95K---18.95K88.06%-6.19K---------181.36%-134.26K--0-86.67%-51.88K
Financing cash flow
Cash flow from continuing financing activities -88.51%4.06M4.06M0176.54%35.35M03,215.45%7.63M
Net common stock issuance ----------0--0--0--------194.69%27.73M--0--0
Proceeds from stock option exercised by employees ---------46.73%4.06M--4.06M--0--------124.02%7.63M--03,215.45%7.63M
Cash from discontinued financing activities
Financing cash flow ---------88.51%4.06M--4.06M--0--------176.54%35.35M--03,215.45%7.63M
Net cash flow
Beginning cash position -96.78%768.86K-76.63%6.45M141.71%27.61M-63.41%12.69M-42.44%17.79M46.70%23.85M141.71%27.61M15.58%11.42M91.51%34.68M58.16%30.9M
Current changes in cash 113.08%792.85K-51.05%-5.68M-230.71%-21.16M11.75%-6.23M-235.17%-5.1M-141.39%-6.06M-177.84%-3.76M951.17%16.19M-5.70%-7.06M363.68%3.77M
End cash Position -91.22%1.56M-96.78%768.86K-76.63%6.45M-76.63%6.45M-63.41%12.69M-42.44%17.79M46.70%23.85M141.71%27.61M141.71%27.61M91.51%34.68M
Free cash flow 67.97%-1.94M-51.05%-5.68M-31.61%-25.22M-45.76%-10.3M-32.48%-5.1M-57.27%-6.06M14.39%-3.76M-70.44%-19.16M-5.70%-7.06M-131.78%-3.85M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Concept Mpox (monkeypox)
Mpox (monkeypox)
Intraday-0.84%